Does active surveillance of serious and life-threatening adverse drug reactions improve reporting?
作者信息
Zimmerman Margaret, Grenier Danielle, Levitt Miriam
机构信息
Patient Safety Section, Therapeutic Effectiveness and Policy Bureau, Marketed Health Products Directorate, Health Canada;
出版信息
Paediatr Child Health. 2011 Nov;16(9):532-4. doi: 10.1093/pch/16.9.532.
Abstract
摘要
相似文献
1
Does active surveillance of serious and life-threatening adverse drug reactions improve reporting?对严重及危及生命的药物不良反应进行主动监测是否能改善报告情况？
Paediatr Child Health. 2011 Nov;16(9):532-4. doi: 10.1093/pch/16.9.532.
2
A comparison of active surveillance programs including a spontaneous reporting model for phamacovigilance of adverse drug events in a hospital.比较主动监测项目，包括一个自发报告模型，用于监测医院中药物不良事件的药物警戒。
Korean J Intern Med. 2012 Dec;27(4):443-50. doi: 10.3904/kjim.2012.27.4.443. Epub 2012 Nov 27.
3
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.四价重组流感疫苗上市后安全性监测：疫苗不良事件报告系统报告。
Vaccine. 2021 Mar 26;39(13):1812-1817. doi: 10.1016/j.vaccine.2021.02.052. Epub 2021 Mar 5.
4
Awareness of Adverse Drug Reactions and its Reporting among Third-year Undergraduate Medical Students.本科三年级医学生对药物不良反应的认知及其报告情况
J Nepal Health Res Counc. 2022 Mar 13;19(4):762-766. doi: 10.33314/jnhrc.v19i04.3714.
5
Characterization of Serious Adverse Drug Reactions in Hospital to Determine Potential Implications of Mandatory Reporting.医院严重药品不良反应的特征分析，以确定强制报告的潜在影响。
Can J Hosp Pharm. 2018 Sep-Oct;71(5):316-323. Epub 2018 Oct 31.
6
[Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].[药物不良反应报告不足，这一问题也涉及到需额外监测的药物。来自关于新型口服抗凝剂的单中心经验的初步数据]
G Ital Cardiol (Rome). 2018 Jan;19(1):54-61. doi: 10.1714/2852.28779.
7
[Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].[临床试验中的不良反应记录与报告。依据修订德国药品法（AMG）的第12条法律及药物临床试验质量管理规范（GCP）条例的新法律规定]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Feb;48(2):173-80. doi: 10.1007/s00103-004-0986-1.
8
Estimation of the Under-Reporting of Suspected Serious Adverse Drug Reactions in Japan Using An Interrupted Time Series Analysis.利用中断时间序列分析估计日本疑似严重药品不良反应报告的漏报情况。
Ther Innov Regul Sci. 2022 Mar;56(2):358-365. doi: 10.1007/s43441-022-00379-z. Epub 2022 Feb 5.
9
Surveillance of suspected adverse reactions to natural health products in Italy.意大利对天然健康产品疑似不良反应的监测。
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):626-35. doi: 10.1002/pds.1566.
10
Adverse drug events caused by serious medication administration errors.严重给药错误导致的药物不良事件。
BMJ Qual Saf. 2012 Nov;21(11):933-8. doi: 10.1136/bmjqs-2012-000946. Epub 2012 Jul 12.
引用本文的文献
1
Study of Natural products Adverse Reactions (SONAR) in children seen in mental health clinics: a cross-sectional study.在心理健康诊所就诊儿童中开展的天然产物不良反应研究（SONAR）：一项横断面研究。
BMJ Paediatr Open. 2020 Sep 28;4(1):e000674. doi: 10.1136/bmjpo-2020-000674. eCollection 2020.
本文引用的文献
1
An innovative web based system for reporting rare diseases in paediatrics.一种用于报告儿科罕见疾病的创新型基于网络的系统。
Online J Public Health Inform. 2015 Jul 1;7(2):e215. doi: 10.5210/ojphi.v7i2.6018. eCollection 2015.
2
Drug investigation for Canadian children: The role of the Canadian Paediatric Society.加拿大儿童药物调查：加拿大儿科学会的作用。
Paediatr Child Health. 2003 Apr;8(4):231-40. doi: 10.1093/pch/8.4.231.
3
Paediatric adverse drug reaction reporting: understanding and future directions.儿科药物不良反应报告：理解与未来方向
Can J Clin Pharmacol. 2007 Winter;14(1):e45-57. Epub 2007 Feb 12.
Zotero 插件